Description KEY ROLES AND RESPONSIBILITIES Develop and maintain business relationships with existing and potential new clients in Europe for Piramal’s medicinal chemistry services business. Selling Piramal Pharma Solutions, Ahmedabad, India based small molecule discovery services including synthetic chemistry, In-vitro biology, In-vitro ADME, In-vivo PK & Route Scouting/ Non-GMP scale up services in Europe Identify and engage with new prospective clients and maintain existing business Coordinate initial client visits to the Piramal’s Discovery Services facility in India Prepare and deliver client proposals in collaboration with Program Managers Negotiate agreements of sale and achieve yearly sales objectives Managing Sales activities on a CRM platform Contribute to the implementation of marketing initiatives including providing market information, attending relevant tradeshows Develop and maintain a current understanding of the external marketplace (e.g. conditions, trends and competitors) as well as internal capabilities and technologies Maintain a current knowledge of sales and project management skills and technique SKILLS AND COMPETENCIES Solid and demonstrable experience of selling medicinal chemistry, preclinical research services into biotech, mid-size and large pharmaceutical companies in Europe. Should have a strong network within European biotech/ pharma community. Selling for Asian Providers previously is strongly desirable. Solid demonstration of negotiation and sales skills including strategic thinking and key account management Strong communication skills Willingness and ability to learn and grasp new ideas both independently and collaboratively Highly organized with an ability to work effectively to deadlines. A high attention to detail with an ability to follow through on commitments Qualifications QUALIFICATION: Minimum requirement of a MS in any Life Sciences (Preferably Chemistry), PhD and / or MBA desired EXPERIENCE: 5 to 10 years of experience selling small molecule medicinal chemistry services to the pharmaceutical/biotechnology industry in Europe